The main goal of LTSM Systems is the commercialization of a sleep apnea home diagnosis medical device.
Sleep apnea is a sleep disorder that is considered an important factor for morbidity and mortality due to its direct effect on the cardiovascular system. It is estimated that 20% of the population in developed countries suffers from sleep disorders. Sleep apnea counts for more than one third of the cases.
Sleep apnea is diagnosed by using a sleep monitor that records multiple parameters during sleep. The recordings are performed either in a hospital environment or at home. Due to the limited hospital infrastructure, home diagnosis must be adopted in order to treat the large amount of active cases (currently 80%).
LTSM Systems diagnostic device has higher simplicity and lower price than the current home sleep monitors in the market. Home sleep monitors require a high simplicity in order to be reliably used by the patient. LTSM Systems has been expanding its business plan in order to cover both EU and US markets. In order to achieve our objectives, we are currently looking to expand our current team and include an advisory team.
The market for medical devices for chronic conditions will experiment a continuous growth in the coming years due to the increasing life expectancy in developed societies (18% of Belgians are over 65).